1. STOCK NEWS:

• Novavax (NVAX) said its COVID-19 vaccine showed 90% efficacy in a pivotal Phase 3 trial [more]
• Moderna (MRNA) submitted an application to Swissmedica for its COVID-19 vaccine in adolescents [more]
  
• Lordstown Motors (RIDE) announced the resignation of CEO Steve Burns and CFO Julio Rodriguez [more]
  
• Elon Musk said that Tesla (TSLA) will resume accepting bitcoin when there's confirmation of "reasonable" clean energy usage by miners [more]
  
• Washington Prime (WPG) commenced a voluntary Chapter 11 financial restructuring [more]
  

2. TOP CALLS:

• Raymond James analyst Brian Vaccaro upgraded Chipotle (CMG) to Strong Buy on its menu price hikes [more]
• Crispr Therapeutics (CRSP) was upgraded to Neutral from Sell at Citi [more]
  
• Oatly Group (OTLY) initiated with a Buy at Jefferies, Truist, and Guggenheim, initiated with an Outperform at Credit Suisse, initiated with an Overweight at Piper Sandler, initiated with an Outperform at William Blair, initiated with a Neutral at Exane BNP Paribas and JPMorgan, initiated with an Equal Weight at Morgan Stanley, initiated with a Sector Perform at RBC Capital and initiated with a Perform at Oppenheimer [more]
  
• Core Laboratories (CLB) was downgraded to Sell from Neutral at Citi, with analyst Scott Gruber opening a "negative catalyst watch" into the company's Q2 earnings report [more]
  
• Evercore analyst Steve Sakwa downgraded AvalonBay (AVB to In Line after the firm hosted meetings at NAREIT [more]
  

3. AROUND THE WEB:

• Third Point has a "substantial" Vivendi (VIVHY) stake and is examining the company's deal to sell a 10% stake in UMG, Bloomberg says [more]
• NextGen Acquisition SPAC (NGAC) is in talks to take Virgin Orbit public, Sky News reports [more]
  
• GSK's (GSK) consumer business is planning deals after its split from the pharma business, FT says [more]
  
• Goldman Sachs (GS) is in talks to move some employees to Florida, BI reports [more]
  
• Royal Dutch Shell (RDS.A) is considering a sale of Texas shale assets, Reuters says [more]
  

4. MOVERS:

• RAPT Therapeutics (RAPT) soars after reporting results from its Phase 1b RPT193 trial [more]
• iTeos Therapeutics (ITOS) gains after announcing an agreement with GlaxoSmithKline (GSK) to co-develop and co-commercialise EOS-448 [more]
  
• Brooklyn ImmunoTherapeutics (BTX) higher after executing a non-binding letter of intent to acquire Novellus Therapeutics [more]
  
• Endo International (ENDP) lower after the Tennessee Court of Appeals issued several orders regarding a state court default judgement [more]
  
• Fortress Biotech (FBIO) slips after subsidiary Avenue Therapeutics (ATXI) received a complete response letter from the FDA for IV tramadol [more]
  

5. EARNINGS:

• Motorcar Parts (MPAA) rises after reporting upbeat Q4 revenue [more]
• Kaleyra (KLR) slips after providing Q2 revenue guidance [more]
  
• Cano Health (CANO) gains after reiterating its FY21 revenue guidance [more]
  
• Coda Octopus Group (CODA) jumps after reporting better-than-expected Q2 results [more]
  
• Duke Energy (DUK) higher after providing five-year EPS CAGR targets [more]
  

INDEXES:

Near midday, the Dow was down 222, or 0.64%, to 34,257.60, the Nasdaq was up 47.06, or 0.33%, to 14,116.48, and the S&P 500 was down 10.43, or 0.25%, to 4,237.01.